None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Late subacute or chronic stroke (=3 months post-onset) (2) unilateral ischemic or hemorrhagic stroke (3) hemi-paresis
Exclusion criteria
Exclusion criteria: (1) Neurological disorder other than stroke (2) Receiving botulinum toxin on the impaired arm within 3 months (3) Cognitive dysfunction that precludes comprehension of experimental tasks and the provision of written informed consent (score lower than 18 on the Korean version of Mini-Mental Status Examination) (4) Severe spasticity (Modified Ashworth <4) (5) Sign of severe concurrent medical problems (including shoulder pain) sufficient to preclude repetitive reaching to targets (verbally asked during pre-screening)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle synergy (composition and activation of muscle synergies);Brain activity and functional connectivity of regions of interest;End-point force (direction, magnitude, and moment in 3D force space);Level of upper limb motor impairment (Fugl-Meyer Assessment);Upper limb motor function (Wolf Motor Function Test) | — |
Secondary
| Measure | Time frame |
|---|---|
| Upper limb joint motion (3D translation of glenohumeral joint center, 3 DOF rotation of shoulder and 1 DOF rotation of elbow | — |
Countries
Korea, Republic of
Contacts
Korea Advanced Institute of Science and Technology